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ABSTRACT

The Present invention provides orthopedic prosthesis having
at least One
component that
a
substrate on which an integrally formed nano-crystalline
coating is formed. The coating and the substrate have at least
one metallic constituent in common having an average
atomic concentration in the coating that differs from an
average atomic concentration in the substrate by less than
about 10 percent. Further, the nano-crystalline coatings
includes crystalline grains with an average size in a range of
about 1 to 999 nanometers, and more preferably in a range
of about 10 to 200 nanometers. A transition region that
exhibits a graded reduction in average grain size separates
the coating from the substrate. The coating advantageously
exhibits an enhanced hardness, and a high degree of resistance to corrosion and wear. In one application, the nanocrystalline coatings of the invention are utilized to form
articulating surfaces of various orthopedic devices.

59 Claims, 5 Drawing Sheets
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NANO-CRYSTALLINE, HOMO-METALLIC,
PROTECTIVE COATINGS

SUMMARY OF THE INVENTION

BACKGROUND
5

The present invention relates generally to metallic struttures having protective coatings and methods for producing
such structures, More particularly, the invention provides
metallic components for incorporation in orthopedic prosthesis which include surfaces having integrally formed protective coatings that exhibit a high degree of hardness, wear
and corrosion resistance.
Metallic structures are utilized in a variety of devices. For
example, many prosthetic devices include metallic ComPonents. In particular, prosthetic joints, utilized in total joint
arthro~lasty(TJA) procedures to restore mobility in patients
with reduced joint function, typically include two mating
and articulating surfaces, one of which is formed of a metal
alloy such as titanium-aluminum-vanadium or cobalt-chromium-molybdenum, and the other is formed andor lined
with a plastic component, such as ultrahigh molecular
weight polyethylene (UHMWPE).
The recent trends in performing arthroplasty on younger
and more active patients have increased the demand for
enhanced prosthetic joint function and lifetime. The lifetime
of total joint replacement components is typically limited
either by gross failure of the materials of the articulating
surfaces (primarily the UHMWPE component) or by biological reactions to debris generated from the wear of the
articulating surfaces. UHMWPE wear particles have been
implicated as a major contributing factor to bone resorption,
joint loosening, and osteolysis, necessitating replacement of
the prosthetic components. In addition, wear debris can
result in the formation of scar tissue which, in turn, can lead
to decreased joint mobility and pain. For example, wear of
the UHMWPE acetabular component in artificial hips has
been measured to be between 0.02 and 0.25 mndyear, with
an average wear rate of about 0.07 mndyear.
Anumber of mechanisms can contribute to the rate of the
wear of UHMWPE articulating surfaces. One such mechanism is abrasive wear which is caused primarily by surface
asperities on a hard metallic or ceramic surface in contact
with the UHMWPE articulating surface. Further, wear particles, such as metallic and ceramic particles, corrosion
products, and bone fragments can migrate to the joint
capsule and accumulate at bone prosthesis interface. These
third body wear particles, produced primarily from components of bone cement used to secure the joints, produce a
wear environment that facilitates roughening of the metallic
surfaces.
onesuggested approach for lowering the wear rate of
UHMWPE components in such prosthetic devices is to coat
the metallic mating surfaces with hard ceramics. However,
such ceramic coatings have a number of drawbacks. For
example, it is difficult to achieve adequate adhesion between
the metal and the ceramic. Further, such ceramic coatings
are brittle and can render manufacturing of the prosthetic
devices which utilize them difficult and costly.
n u s , a need exists for protective coatings on metallic
surfaces that can enhance the hardness, and the wear and
corrosion resistance of such surfaces. Further, a need exists
for metallic components in prosthetic devices which exhibit
a high degree of wear and corrosion resistance. In addition,
a need exists for methods of manufacturing such coatings
which are easy to implement and are also cost effective.
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The present invention provides, nano-crystalline, homometallic coatings having average grain sizes in a range of
about 1 to about 999 nanometers. The term "homo-metallic
coating", as used herein, refers to a coating, formed on a
metallic substrate, which has at least one metallic constituent element in common with the metallic substrate. For
when the substrate is formed of a Coxr-Mo
alloy, a homo-metallic coating can be formed of a Co-Cr
alloy, a C o x r - M o
alloy, a Cr-Mo alloy, a Co-Mo
alloy, chromium, cobalt, or molybdenum,
In one aspect, the present invention provides an orthopedic prosthesis for implantation in a patient that includes at
least one metallic component formed of a metallic substrate
having a homo-metallic protective coating integrally formed
thereon. The coating and the substrate have at least one
metallic constituent in common. The average atomic concentration of the common metallic constituent in the coating
differs from its average concentration in the substrate by less
than about 20 percent, and more preferably, by less than
about 10 percent. Further, the protective coating has a
nano-crystalline structure with average grain sizes ranging
from about 1 nanometer to about 999 nanometers, and
preferably from about 1 nanometer to about 500 nanometers,
and more preferably from about 10 nanometers to about 200
nanometers. A transition region that exhibits a graded reduction in average grain size of the common metallic constituent separates the coating from the substrate. For example,
the average crystalline grain size can decrease continuously
from the substrate to the coating within the transition zone.
Such a transition zone can advantageously enhance the
adhesion of the coating to the substrate.
The common metallic constituent can be, for example,
cobalt having an average atomic concentration in a range of
about 40 to about 75 percent, and preferably in a range of
about 45 to about 65 percent, and more preferably, in a range
of about 50 to about 60 percent. Further, the substrate and
the coating can include more than one common metallic
constituents. For example, in addition to cobalt, the substrate
and the coating can both include chromium (Cr) at an
average atomic concentration in the substrate in a range of
about 30 to about 65 Percent, and preferably, in a range of
about 35 to about 55 Percent, and more preferably in a range
of about 40 to about 50 Percent, and an average atomic
concentration in the coating which differs from that in the
substrate by less than about 20 Percent, and more preferably,
by less than about 10 percent.
, Alternatively, the common metallic constituent can be
titanium (Ti). For example, the substrate and the coating can
be formed of a Ti-6A1-4V alloy. In yet another example, a
nano-crystalline coating of stainless steel can be deposited
On a stainless steel substrate.
The substrate andor the coating can also include other
metallic elements. For example, the substrate can include
molebdynum (Mo) as one of its constituents. In particular, in
one embodiment, the substrate includes a Co5,,Cr3,,Mo,,
alloy and the nano-crystalline coating includes a Co,SCr39-5
alloy. It should also be understood that the substrate andor
the nanocrystalline coating can include non-metallic elements, such as nitrogen. The concentration of such a nonmetallic element can be, for example, less than about 20
Percent, and more preferably, less than about 10 Percent.
According to other aspects, the protective coating can
have a thickness ranging from about 0.05 microns to about
a few millimeters. Alternatively, the thickness of the coating
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can range from about 0.05 microns to about 10 microns, or
the temperature of the substrate. In such an embodiment, the
from about 0.3 microns to about 3 microns.
deposition and ion bombardment steps resume while the
A "nanocrystalline coating" according to the invention
substrate is at room temperature. These processes can,
typically will have an average crystalline grain size that is
however, raise the substrate temperature above its initial
approximately 100 times to 400 times less than the average 5 value.
crystalline grain size of the underlying substrate. AccordIn another aspect, the invention provides methods as
described above in which the deposition rate of the metallic
ingly, a nano-crystalline coating of the invention advantageously generally exhibits substantially greater hardness
substance and the current density of the incident ion beam
than that of the underlying substrate. For example, the
are selected such that a ratio of the substance atoms deposhardness of the protective coating of the invention can be l o ited on the substrate per second relative to the number of
about lo%, and more preferably 30%, greater than that of
ions incident on the substrate per second is in a range of
the substrate. The hardness of a nano-crystalline coating of
about 1 to about 10.
the invention typically will be in a range of approximately
Illustrative embodiments of the invention are described
below with reference to the following drawings.
10 to about 30 GPa.
In another aspect, an orthopedic prosthesis according to 1s
BRIEF DESCRIPTION OF THE DRAWINGS
the teachings of the invention can include a plastic component that can articulate against the metallic component,
FIG. 1 schematically illustrates a graded nano-crystalline
which is at least partially coated with a homo-metallic
homometallic C o X r alloy coating deposited on a microcoating according to the teachings of the invention. The
plastic component can be formed of a variety of materials 20 crystalline C o X r prosthesis surface in accordance with the
teachings of the invention,
known in the art. For example, the plastic component can be
FIG. 2 is a diagram illustrating measured nano-hardness
formed or lined with ultra-high molecular weight polyethof a C o X r nano-crystalline coating and its comparison
ylene (UHMWPE). The prosthesis can be, for example, an
with the nano-hardness of a Co-Cr-Mo
substrate on
artificial hip, an artificial knee, or an artificial shoulder.
In another aspect, a transition region separating a homo- 25 which the coating can be deposited,
FIG. 3 presents a comparison of the measured Young's
metallic nano-crystalline coating of the invention from the
moduli for a plurality of nano-crystalline C o X r coatings
substrate on which the coating is deposited is characterized
with the Young's modulus of a CoXr-Mo substrate on
by a graded variation of concentration of the common
which the coatings are deposited,
metallic constituent from the protective coating to the subFIG. 4 presents a comparison of the potentiodynamic data
strate.
30
for a nano-crystalline Co-Cr
film in accord with the
In another aspect, the invention provides methods for
teachings of the invention with the data for a C o X r - M O
producing a protective coating on a metallic surface of a
bulk substrate illustrating significantly improved static cormetallic component of an orthopedic prosthesis. One such
rosion behavior of the nano-crystalline coating,
method calls for depositing a dose of a metallic substance on
FIG. 5 is a schematic illustration of an IBAD apparatus
a metallic substrate, where the deposited substance and the 35
suitable for producing homo-metallic nano-crystalline coatsubstrate have at least one metallic constituent element in
common. The deposition step can be performed, for
ings in accord with the teachings of the invention,
FIG. 6A is a schematic illustration of a hip joint prosthesis
example, by evaporating the metallic substance and deposthat includes a metallic femoral head having a metallic
iting the evaporated atoms onto the substrate.
Concurrent with the deposition step, the metallic surface 40 surface coated according to the teachings of the invention
articulating against the surface of a cup lined with UHMis bombarded with one or more selected ions so as to form
WPE,
a nano-crystalline integral protective coating on the surface,
FIG. 6B schematically illustrates coated surface of the
having average grain sizes ranging from about 1 -to about
CUP in hip joint prosthesis of FIG. 6A against which the
999 nm, and having an average atomic concentration of the
common constituent element that differs from its average 45 femoral head articulates,
FIG. 7 schematically illustrates a knee joint prosthesis
concentration in the metallic surface by less than about 20
having an articulating surface formed as a nano-crystalline
percent, and more preferably, by less than about 10 percent.
homo-metallic film in accord with the teachings of the
An ion beam, e.g., argon or nitrogen or a mixture of argon
invention.
and nitrogen, can be directed onto the substrate to assist in
50
the formation of the integral coating.
DETAILED DESCRIPTION
The ion beam incident on the substrate can have a current
density in a range between about 1 to about 500 microThe present invention provides metallic structures having
amperes per square centimeters (pA/cm2). Further, the
integrally formed, homo-metallic, protective coatings with
energy of the ion beam can be selected to be in a range of
about 0.05 keV to about 10 k e y and more preferably, from 55 nano-crystalline structures. The nano-crystalline structures
about 0.1 keV to about 2 keV. Further, the deposition rate of
of the coatings include crystalline grains with mean sizes in
the metallic substance over the substrate can be in a range of
a range of about 1 nanometers to about 999 nanometers.
about 0.1 to about 1000 angstroms per second (msec),
More preferably, the average crystalline grain sizes of the
preferably from about 0.1 to about 100 angstroms per
coatings are in a range of about 10 to 200 nanometers. The
second, and more preferably, from about 0.5 to about 50 60 nano-crystalline coatings of the invention advantageously
exhibit a high degree of hardness, and enhanced wear and
angstroms per second.
corrosion resistance properties.
In another aspect, the metallic surface can be selected to
be any of a C o X r , CoXr-Mo, or a titanium alloy.
FIG. 1 schematically illustrates a metallic structure 10
Moreover, the deposition and ion bombardment steps can
formed in accord with the teachings of the invention that can
be performed while the substrate is maintained at a variety 65 form at least a portion of a metallic component of an
of different temperatures. For example, in one embodiment,
orthopedic prosthesis of the invention. The metallic strucno heating or cooling provisions are provided for stabilizing
ture 10 includes a cobalt-chromium ( C o X r ) substrate 12
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and a Co-Cr nano-crystalline coating 14. The substrate 12
includes a plurality of micron-sized crystalline grains. In
contrast, the coating 14 includes crystalline grains with sizes
that are approximately 100 to 400 times smaller than those
of the substrate 12. More specifically, the average grain sizes
of the coating 14 can be in a range of about 1 to about 999
nanometers.
A nano-crystalline coating of the invention, such as the
coating 14 above, can have a thickness in a range of about
0.1 microns to a few millimeters, M~~~ preferably, the
thickness of the nano-crystalline coating is in a range of
approximately 0.5 to 3.0 microns. The coating and the
substrate can have a non-discrete (graded) interface boundary, l-hat is, a transition zone, having crystalline grain sizes
with values intermediate those of the coating and the substrate, can separate the coating from the bulk substrate.
In one aspect, the invention provides metallic structures
that exhibit a gradual reduction of crystalline grain size from
a homo-metallic coating layer to the bulk substrate, Such a
gradual reduction of the grain size advantageously ensures
an enhanced adhesion of the coating layer with the remainder of the structure. Further, the nano-crystalline grain
of the coating provides superior hardness
pared with corresponding materials having larger crystalline
grain sizes, thus
the durability of the coating,

The nano-crystalline coatings of the invention also exhibit
a substantial increase in corrosion resistance relative to the
bulk substrate material. For example, FIG. 4 presents a
comparison of the potentiodynamic polarization data for a
C o X r film of the invention having crystalline grains with
an average size of about 10 nm with data for a CoXr-Mo
bulk substrate having crystalline grains with an average size
of about 8 microns on which the Co-Cr film is deposited.
This comparison illustrates that the C o X r nano-crystalline
coatings of the invention exhibit significantly improved
static corrosion behavior relative to the wrought C o X r MO alloy samples.
A number of techniques can be utilized to form homometallic nano-crystalline coatings, such as those described
above. For example, one embodiment of the invention
generates integrally formed nano-crystalline homo-metallic
coatings on metallic substrates by utilizing an ion beam
assisted
(IBAD) process. In particular, physical
with
beam
to
produce
a
wide
variety of
barbent can be
nano-crystalline homo-metallic coatings in accord with the
of the invention.
FIG. 5 schematically illustrates an IBAD system 16 that
is suitable for the practicing the invention. Such IBAD
are
in the art.
U.S. Pat.
5,236,509, herein incorporated by reference, describes an
IBAD apparatus that is suitable for use in producing homometallic nano-crystalline coatings in accord with the teachings of the invention,
The exemplary IBAD system 16 includes a vacuum
chamber 18 in which a substrate holder 20, an electron beam
evaporator 22, and an ion source 24 are placed, A base
pressure less than about 10-6
and an operating pressure
of approximately 10-5
are typically maintained in the
chamber 18, The holder 20 permits positioning a plurality of
substrates 26 in the chamber 18 for subsequent processing,
as discussed below,
The processing of each substrate 26, which results in
creation of an integral coating having a nano-crystalline
can be perhaps better understood by considering
one of these substrates, i.e., substrate 26a, shown in the
insert of FIG. 5 . The substrate 26a is exposed to a vapor flux
of atoms of a selected material, e.g., a metal such as Co or
Cr or an alloy such as Co-Cr, or stainless steel, generated
by the electron beam evaporator 22 to grow a film of the
selected material over the substrate,
Concurrent with the vapor deposition, the growing film is
bombarded with ions of a selected gas, e.g., argon, generated
by the ion source 24, ~h~ ion energies are
to be in
a range of about several hundred to several thousand electron volts ( e ~ )e,g,,
,
in a range of approximately 500 e~ to
approximately 2000 eV. More preferably, the ion energies lie
in a range of about 500 eV to about 1000 eV. The current
density ofthe ion beam ranges from about 50 microamperes
per square centimeter (pA/cm2) to about 300 microamperes
per square centimeter ( p ~ c m 2 ) ,
1, general, the IBAD process includes a number of
each ofwhich can influence the properties ofthe
,,,ting film generated on a substrate surface, some
ofthese
parameters include deposition rate, ion species, ion energy
and ion beam current density. Metal evaporation rates utilized to create integral metal coatings in accord with the
invention can vary from about 2 angstroms per second (&s)
to approximately 50 (&s). More preferably, the deposition
rate is selected to be in a range of about 2 angstroms per
second (&s) to about 20 &s to ensure that the ion bombardment is effective in modulating the properties of the

The coating
e.g., homometallic coatings, of the
invention provide a number of distinct advantages. For
example, corrosion studies performed on Co-Cr coatings
formed on CoXr-Mo
substrates in accord with the
teachings of the invention (See
indicate
that such coatings exhibit at least one order of magnitude
increase in corrosion resistance compared with the bulk
material. Further, nano-crystalline coatings of the invention
exhibit a high degree hardness, e.g., in a range
l o to 30 GPa. For
nano-crystalline
'Oatings formed on C o X r - M o substrates in accordance with
the teachings of the invention exhibit hardness close to those
of some ceramics, such as TiN, CrN, A1203 and Zr203,
without having the associated problems of adhesion to metal
substrates.
FIG. 2 Presents a comparison of nano-indentation measurements for a Co-Cr nano-crystalline coating deposited
on a CoXr-Mo substrate in ~~Ccord
with the teachings of
the invention. The measurement of the coating hardness was
conducted by utilizing an ultramicro-indentation system
which employs a sharp Berkovich dkmond (three-sided
diamond) indenter with a minimum force of 0.1 mN. The
maximum load was adjusted such that the maximum penetration depth corresponded to less than 1 0 ~ 1 5 %of the
coating thickness to minimize the influence of the substrate
on the measurements. Further, the applied force was incremerited in 30 steps in a square root Progression until the
maximum load was achieved. This was followed by a hold
segment of about 100 seconds to allow for relaxation of
induced plastic flow and creep. Finally, the unloading segment was measured by decreasing the force. The measurements indicate that the nano-crystalline coating exhibits a
substantial increase in hardness relative to that of the bulk
substrate.
FIG. 3 presents measurements of the Young's modulus for
a number of homo-metallic nano-crystalline coatings. An
inspection of the graphs of FIG. 3 illustrates that the Young's
moduli of these nano-crystalline coatings are advantageously much larger than the Young's modulus of the
substrate, attesting to the enhanced hardness of such coatings.
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growing film. The current density of the ion beam bombard38 includes condyles 42 which provide the articulating
ing the substrate can be in a range between about 50 to about
surface of the femoral component and pegs 44 that allow
200 microamperes per square centimeter. Moreover, the
attachment of the femoral component to the femur. The tibial
energy of the ion beam can be selected to be in a range of
component 40 includes a tibial base 46 with a peg 48 that
5 allows mounting the tibia1 base onto the tibia. The tibia1
about 0.5 keV to about 1 keV.
One embodiment of the invention preferably utilizes
component 40 further includes a platform 5 0 , mounted on
argon ions for bombardment of the substrate. Argon is an
the base 46, and having grooves 52 with a shape similar to
that of the condyles 42. The condyles 42 articulate within the
inert gas, and hence does not create potential complications
grooves 52 against the tibial platform 4 8 . The tibial platform
associated with the presence of a reactive element in the
alloy coating. Alternatively, nitrogen ions or a mixture of l o can be formed of andor lined with an organic polymer, such
argon and nitrogen ions can be utilized for bombarding the
as UHMWPE. The condyles 42 can be formed of metallic
substrate.
structures according to the invention. In particular, the
The IBAD process can be performed while the substrate
condyle surfaces articulating within the grooves 52 can be
formed of homometallic nano-crystalline films in accord
is maintained at any desired temperature. In some embodiof the invention.
ments of the invention., no nrovision is nrovided for raising
u 1s with the teachinns
u
the substrate temperature above a value determined by the
Those skilled in the art will appreciate that various
ambient temperature and the impact of atoms and ions on the
modifications can be made to the above embodiments withsubstrate. In other embodiments, the substrate temperature is
out departing from the scope of the invention. For example,
raised to a higher value, e.g., 400" C. In yet other embodithe metallic substrates on which nano-crystalline homoments. the substrate temnerature can be modulated durinn
u 20 metallic coatinns
u in accord with the teachinns
u of the inventhe simultaneous evaporation and bombardment to create a
tion can be formed are not limited to those described above.
gradient of crystalline grain size in a homo-metallic film
Moreover, the applications of homo-metallic coatings of the
deposited on the substrate.
invention are not limited to orthopedic devices.
Other techniques for producing homo-metallic coatings in
The following example provides further illustration of the
accord with the teachings of the invention include, but are 25 invention including exemplary methods for generating
nano-crystalline homo-metallic coatings on metallic subnot limited to, sputtering, plasma immersion, and laser
ablation.
strates. This examples is provided only for illustrative purThe methods of the invention can be utilized to form
poses, and is not intended to be limiting of the scope of the
invention.
nano-crystalline coatings on metallic structures having a
variety of geometrical shapes. For example, spherical metal- 30
EXAMPLE 1
lic components having homometallic coatings with nanocrystalline grains can be produced in accord with the teachA plurality of nano-crystalline coatings of Co-Cr was
ings of the invention.
formed on a CoXr-Mo substrate (F799 substrate) having
The metallic structures of the invention having homometallic nano-crystalline coatings can find a variety of appli- 35 an average chemical composition of C O ~ ~ . , ~ C ~ , ~ . ~ M O , , .
cations. For example, such metallic structures can form
The chemical composition of the substrate was determined
by utilizing Rutherford Backscattering Spectrometry.
components of various orthopedic devices, such as hip
To produce these films, a C o X r alloy was evaporated
joints, knee joints, and elbows. Such orthopedic applications
and the evaporated atoms were directed to the surface of the
of metallic structures of the invention provide a number of
advantages. For example, the use of superhard, nano-crys- 40 substrate. Concurrently, the substrate was bombarded with a
talline coatings significantly ameliorates the generation of
beam of argon ions, having a current density in a range of
wear debris at the articulating interface, thereby providing
about 50 to 150 microamperes per square centimeter (PA/
increased UHMWPE longevity and decreased osteolytic
cm2) and an ion energy of 500 or 600 eV. The process of
response. Other benefits can include, for example, a reducsimultaneous deposition and ion bombardment of the subtion of polyethylene wear associated with scratched metal 45 strate continued for a selected time period to produce a
prostheses, reduction of backside wear in tibial trays and
nano-crystalline film having a desired thickness.
TEM studies of these C o X r coatings show that the grain
rotating and sliding meniscal bearing tibia1 components.
sizes of the coatings range from about 20 nm to about 40 nm.
By way of example, FIG. 6A illustrates a typical hip joint
prosthesis 28 having a stem 30, which fits into the femur, a
That is, the coatings include grains having sizes that are a
femoral head 32, and an acetabular cup 34 against which the 50 few hundred times smaller than those of the bulk substrate.
femoral head articulates. As shown schematically in FIG.
Further, these studies show that the nano-crystalline coatings
6B, the acetabular cup 34 can be lined with one or more
are substantially free of dislocations. Moreover, electron
layers 34a formed of an organic polymer or polymer comdiffraction pattern obtained from a 2-micron area of this
posites. For example, ultra-high molecular weight polyethcoating showed a plurality of rings, thus confirming the
ylene (UHMWPE) can be utilized to provide a polymer 55 presence of a fine-grain structure. Coatings exhibit a hardlining on an articulating surface 34a of the acetabular cup
ness of 12 to 30 GPa.
34. The femoral head 32 can be formed of a metallic
What is claimed is:
1.An orthopedic prosthesis for implantation in a patient
component in accord with the teachings of the invention
comprising
having a metallic substrate on which a protective coating
at least one metallic component comprising
with a nano-crystalline structure is integrally formed. For 60
a metallic substrate, and
example, the femoral head can be formed of a C o X r - M o
a protective coating integrally formed over said suballoy having a C o X r nano-crystalline coating in the accord
with the teachings of the invention.
strate, the coating and the substrate having at least
As another example of the use of homometallic nanoone metallic constituent in common having an avercrystalline coatings of the invention, FIG. 7 schematically 65
age atomic concentration in the coating that differs
from an average atomic concentration in the subdepicts a knee joint prosthesis 36 having a femoral component 38 and a tibia1 component 40. The femoral component
strate by less than about 20 percent, and said proL
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tective coating having a nanocrystalline structure
with average grain sizes ranging from about 1
nanometer to about 999 nanometers, and
a transition region extending from the coating to the
substrate.
2. The orthopedic prosthesis of claim 1, wherein an
average atomic concentration of said common metallic
constituent in the coating differs from an average atomic
concentration in the substrate by less than about 10 percent.
3. The orthopedic prosthesis of claim 1, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 40 to about
75 percent.
4. The orthopedic prosthesis of claim 1, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 45 to about
65 percent.
5. The orthopedic prosthesis of claim 1, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 50 to about
60 percent.
6. The orthopedic prosthesis of claim 2, wherein said
substrate further
(Cr) having
an average atomic concentration in a range of about 30 to
about 65 percent.
7. The orthopedic prosthesis of claim 2, wherein said
metallic substrate further comprises chromium (Cr) having
an average atomic concentration in a range of about 35 to
about 55 percent.
8. The orthopedic prosthesis of claim 2, wherein said
metallic substrate further comprises chromium (Cr) having
an average atomic concentration in a range of about 40 to
about 50 percent.
9, The orthopedic prosthesis of claim 6, wherein the
coating further comprises chromium (Cr) having an average
atomic concentration that differs from the average atomic
concentration of chromium in the substrate by less than
about 20 percent.
10. The orthopedic prosthesis of claim 6, wherein the
coating further comprises chromium (Cr) having an average
atomic concentration that differs from the average atomic
concentration of chromium in the substrate by less than
about 10 percent.
11. The orthopedic prosthesis of claim 3, wherein the
metallic substrate further comprises molebdynum (Mo).
12. The orthopedic prosthesis of claim 1, wherein at least
one of the substrate or the coating comprises a non-metallic
substance having an atomic concentration less than about 20
percent.
13. The orthopedic prosthesis of claim 12, wherein said
non-metallic substance is nitrogen.
14, ~h~ orthopedic prosthesis of claim 1, wherein the
metallic substrate comprises a Co5,,Cr3,,Mo,,
alloy and
the nano-crystalline coating comprises a Co,,,Cr3,,
alloy.
15. The orthopedic prosthesis of claim 1, wherein said
common metallic constituent comprises titanium.
16. The orthopedic prosthesis of claim 9, wherein said
substrate and said coating comprise a Ti-6A1-4V alloy.
17. The orthopedic prosthesis of claim 1, wherein the
protective coating has a thickness ranging from about 0.05
microns to about a few millimeters.
18. The orthopedic prosthesis of claim 1, wherein the
protective coating has a thickness ranging from about 0.05
microns to about 10 microns.
19. The orthopedic prosthesis of claim 1, wherein the
protective coating has a thickness ranging from about 0.3
microns to about 3 microns.

20. The orthopedic prosthesis of claim 1, wherein an
average grain size of the protective coating ranges from
about 1 nanometer to about 500 nanometers.
21. The orthopedic prosthesis of claim 20, wherein an
average grain size of the protective coating ranges from
about 10 nanometers to about 200 nanometers.
22. The orthopedic prosthesis of claim 21, wherein an
average grain size of the protective coating ranges from
about 50 nanometers to about 200 nanometers.
23. The orthopedic prosthesis of claim 1, wherein the
protective coating exhibits a greater hardness than the substrate.
24. The orthopedic device of claim 23, wherein the
hardness of the protective coating is about 10% greater than
that of the substrate,
25, ~h~ orthopedic prosthesis of claim 23, wherein the
hardness of the protective coating is about 30% greater than
that ofthe substrate,
26, l-he orthopedic prosthesis of claim 1, further
prising a
component articulating against the metallic
component.
27, l-he orthopedic prosthesis of claim 26, wherein the
plastic component is formed of ultra-high molecular weight
polyethylene,
28. The orthopedic prosthesis of claim 26, wherein the
prosthesis is an artificial hip,
29, The orthopedic prosthesis of claim 26, wherein the
prosthesis is an artificial knee,
30. The orthopedic prosthesis of claim 26, wherein the
prosthesis is an artificial shoulder,
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31. An orthopedic prosthesis for implantation in a patient
comprising
at least One
component
a
substrate, and
a metallic protective coating integrally formed over
said substrate, the coating and the substrate having at
least one metallic constituent in common such that a
concentration of said constituent in the coating differs from a concentration of said constituent in the
substrate by less than about 20 percent, and said
protective coating having a nanocrystalline structure
with average grain sizes ranging from about 1
nanometers to about 999 nanometers, and
a transition region extending from the coating to the
substrate.
32. The orthopedic prosthesis of claim 31, wherein an
atomic concentration of said common metallic constituent in
the coating differs from a concentration of said constituent
less than
l o Percent.
in the substrate
33. The orthopedic prosthesis of claim 31, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 40 to about
75 Percent in said substrate.
34. The orthopedic prosthesis of claim 31, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 45 to about
65 percent in said substrate.
35. The orthopedic prosthesis of claim 31, wherein said
common metallic constituent comprises cobalt having an
average atomic concentration in a range of about 50 to about
60 percent in said substrate.
36. The orthopedic prosthesis of claim 33, wherein said
substrate and said coating include another common metallic
constituent.
37. The orthopedic prosthesis of claim 36, wherein said
another common metallic constituent comprises chromium
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having an average atomic concentration in a range of about
30 to about 65 percent in said substrate.
38. The orthopedic prosthesis of claim 36, wherein said
another common metallic constituent comprises chromium
having an average atomic concentration in a range of about
35 to about 55 percent in said substrate.
39. The orthopedic prosthesis of claim 36, wherein said
another common metallic constituent comprises chromium
having an average atomic concentration in a range of about
40 to about 50 percent in said substrate.
40. The orthopedic prosthesis of claim 37, wherein said
chromium constituent has an average atomic concentration
in said coating that differs from an average atomic concentration of chromium in the substrate by less than about 20
percent.
41. The orthopedic prosthcsis of claim 37, wherein said
chromium constituent has an average atomic concentration
in said coating that differs from an average atomic concentration of chromium in the substrate by less than about 10
percent.
42. The orthopedic prosthesis of claim 31, wherein said
substrate comprises a Co,, ,Cr3, ,Mo, alloy and the nanocrystalline coating comprises a Co,, ,Cr3,, alloy.
43. The orthopedic prosthesis of claim 31, wherein said
common metallic constituent comprises titanium.
44, The orthopedic prosthesis of claim 43, wherein said
substrate and said coating comprise a Ti-6A1-4V alloy.
45, neorthopedic prosthesis of claim 31, wherein the
protective coating has a thickness ranging from about 0.05
microns to about a few millimeters.
46. The orthopedic prosthesis of claim 31, wherein the
protective coating has a thickness ranging from about 0.05
microns to about 10 microns.
47. The orthopedic prosthesis of claim 31, wherein the
protective coating has a thickness ranging from about 0.3
microns to about 3 microns.

48. The orthopedic prosthesis of claim 31, wherein an
average grain size of the protective coating ranges from
about 1 nanometer to about 500 nanometers.
49. The orthopedic prosthesis of claim 31, wherein an
average grain size of the protective coating ranges from
about 10 nanometers to about 200 nanometers.
50. The orthopedic prosthesis of claim 49, wherein an
average grain size of the protective coating ranges from
about 50 nanometers to about 200 nanometers.
51. The orthopedic prosthesis of claim 31, wherein the
protective coating exhibits a greater hardness than the substrate.
52, The orthopedic device of claim 51, wherein the
hardness of the protective coating is about 10% greater than
that of the substrate.
53, ~h~ orthopedic prosthesis of claim 51, wherein the
hardness ofthe protective coating is about 30% greater than
that of the substrate,
54, The orthopedic prosthesis of claim 31, further
prising a plastic component articulating against the metallic
component,
55. The orthopedic prosthesis of claim 54, wherein the
plastic component is formed of ultra-high molecular weight
polyethylene,
56. The orthopedic prosthesis of claim 54, wherein the
prosthesis is an artificial hip.
57. The orthopedic prosthesis of claim 54, wherein the
knee.
prosthesis is an
58. The orthopedic prosthesis of claim 54, wherein the
prosthesis is an artificial shoulder.
59. The orthopedic prosthesis of claim 31, wherein the
transition region exhibits a graded reduction in average grain
size from the substrate to the coating.
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